Press Room

There are 4 item(s) tagged with the keyword "Medtronic".

1. JDRF Canada's Diabetes Research Infosiums

We’re excited to announce a new spin on JDRF’s Diabetes Research Symposiums, our signature research event to share exciting updates on JDRF-funded research.  This year, the symposiums are taking a different approach and  will focus on many different trials taking place, instead ...


2. JDRF Applauds Launch of New Low Glucose Suspend Technology

 JDRF, the leading global organization funding type 1 diabetes (T1D) research, today applauded the U.S. Food and Drug Administration (FDA) for its commitment to ensuring patients in the United States can access insulin pumps that can temporarily stop insulin delivery once sensor glucose levels ...


3. JDRF through the Joint JDRF-Helmsley Charitable Trust Initiative Partners with Medtronic

NEW YORK, N.Y., June 1, 2012 -- JDRF in collaboration with the Helmsley Charitable Trust (HCT) announced today a partnership with Medtronic, Inc. (NYSE:MDT), a leader in artificial pancreas research and development. The JDRF-HCT Sensor Initiative aims to advance continuous glucose ...


4. Medtronic Recalls Certain Lots of Paradigm Quick-Set Infusion Sets

OTTAWA - Health Canada is advising Canadians that the company Medtronic has initiated a recall of its Paradigm Quick-set infusion sets with lot numbers beginning with "8" ("Lot 8"). A small percentage of the affected infusion sets may work improperly and may deliver too much or too ...


Lets turn type one into type none